Meeder Asset Management’s NeoGenomics NEO Stock Holding History

Meeder Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-791	Closed	-$7K	–	1550
2022 Q3	$7K	Buy	791 +23	+3%	+$228	﹤0.01%	1454
2022 Q2	$6K	Buy	768 +349	+83%	+$3.33K	﹤0.01%	1588
2022 Q1	$5K	Buy	419 +277	+195%	+$5.83K	﹤0.01%	1804
2021 Q4	$5K	Buy	142 +63	+80%	+$2.47K	﹤0.01%	865
2021 Q3	$4K	Buy	79 +40	+103%	+$1.85K	﹤0.01%	2013
2021 Q2	$2K	Hold	39	–	–	﹤0.01%	2228
2021 Q1	$2K	Buy	39 +3	+8%	+$156	﹤0.01%	2095
2020 Q4	$2K	Buy	36 +20	+125%	+$904	﹤0.01%	1509
2020 Q3	$1K	Hold	16	–	–	﹤0.01%	2011
2020 Q2	$0	Buy	+16	New	+$443	﹤0.01%	2310
2019 Q1	–	Sell	-474	Closed	-$6K	–	1800
2018 Q4	$6K	Sell	474 -101	-18%	-$1.5K	﹤0.01%	1375
2018 Q3	$9K	Buy	+575	New	+$7.95K	﹤0.01%	1190

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Meeder Asset Management's NEO Position: Q4 2022 in Review

Meeder Asset Management sold out of NeoGenomics (NEO) in Q4 2022, closing a stake of 791 shares — an estimated $7K sold.

Meeder Asset Management first reported a position in NEO in Q3 2018 and held it in 12 quarters. The position peaked at $9K in Q3 2018. 242 funds tracked by Wall St. Rank hold NEO as of Q4 2022.

Meeder Asset Management reported no remaining NeoGenomics position as of Q4 2022 after selling out during the quarter.
Meeder Asset Management sold 791 NeoGenomics shares in Q4 2022, an estimated $7K.
Meeder Asset Management first reported a position in NeoGenomics in Q3 2018 and held it in 12 quarters.
Meeder Asset Management's NeoGenomics position peaked at $9K in Q3 2018.
242 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.